Sign in

NCT06518473Completed

Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

The Relation Between Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
14 Jul 2024
Start date
14 Jul 2024
Primary completion date
15 Sept 2025
Lead sponsor
Mansoura University Hospital
Diseases
COPD
NCT number
NCT06518473

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 14 Jul 2024 to the primary completion date, 15 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment.

Other illness

  • Patients with known allergic diseases before enrollment
  • Patients with associated other chronic respiratory disorders

Other

  • Patients with significant comorbidities that could influence respiratory function.

Who the study is looking for

  • Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria

Age in the registry: 40 years to 70 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Mohamed AbdElmoniem
Coordinator of this site? Confirm its status
Al MansurahEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.